T and NK cells as living drugs for cancer therapy


Event Details


The Institute for Cancer Research invites you to an exciting seminar with Professor Dario Campana from the National University of Singapore. 

The topic for the seminar is T and NK cells as living drugs for cancer therapy.

Professor Karl-Johan Malmberg from the Department of Cancer Immunology is hosting this seminar at the main auditorium of the Institute for Cancer Research.

About the speaker
Professor Dario Campana has made several seminal contributions within pediatric hematology and cancer immunotherapy. His achievements include the development of effective methods for monitoring residual disease in acute leukemia leading to high cure rates in childhood acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), the discovery of early T-cell precursor ALL (a subset of ALL with poor response to therapy), the development of the first anti-CD19-41BB-CD3 zeta chimeric antigen receptor as well as of other methods to activate and genetically modify immune cells currently in clinical trials.

Print This Post